Literature DB >> 2978202

Suppression of immunoglobulin production by germinal centre HNK-1+ CD3+ cells.

D Banerjee1, J Baril, D A Bell, D McFarlane, R Karim.   

Abstract

Germinal centre T cells co-expressing HNK-1 antigen have little lytic activity against NK targets (K562 cells). In order to determine whether these cells regulate B cell function, they were purified from human tonsils by panning on anti-HNK-1 antibody coated Petri dishes and co-cultured with autologous and allogeneic tonsillar T and B cells in the presence of pokeweed mitogen. At the end of 7 days of culture, supernatants were assayed for immunoglobulin concentration by ELISA. A dose-dependent suppression of both IgG and IgM production was demonstrated at ratios from 1:125 to 1:16 of HNK-1+ cells to B cells, but enhancement was observed at very low ratios (less than 1:500) or ratios exceeding 1:16 in some tonsil preparations. Similar results were obtained with peripheral blood HNK-1+ cells but without enhancement in some cases at the extremes of HNK-1+ cells to B cell ratios. The suppression was not MHC-restricted. These preliminary experiments indicate that germinal centre HNK-1+ cells may be intrafollicular suppressor cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2978202     DOI: 10.1007/978-1-4684-5535-9_64

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.

Authors:  O W Kamel; A B Gelb; R B Shibuya; R A Warnke
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

2.  Human CD57+ germinal center-T cells are the major helpers for GC-B cells and induce class switch recombination.

Authors:  Jong R Kim; Hyung W Lim; Seung G Kang; Peter Hillsamer; Chang H Kim
Journal:  BMC Immunol       Date:  2005-02-04       Impact factor: 3.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.